Nelli Bejanyan

28PUBLICATIONS
171CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Jul 21, 2026
Chronic graft vs. host disease following post-transplant cyclophosphamide (PTCy) based prophylaxis vs. non-PTCy prophylaxis.

|Jul 17, 2026
A novel severe toxicity-free, and progression-free survival endpoint predicts outcomes after CD19 chimeric antigen receptor-T cell therapy in large B-cell lymphoma.

|Jun 20, 2026
Expanded antigen-specific donor regulatory T cells for GVHD prevention.

|Jun 03, 2026
TA-TMA and GVHD are distinct consequences of endothelial injury: a MIDAS consortium study.

|Apr 08, 2026
Single center evaluation of a composite risk assessment model to predict non-relapse mortality following allogeneic hematopoietic cell transplantation (HCT).

Reshma Ramlal, Jongphil Kim, Zachary Thompson

|Feb 24, 2026
Posttransplant MRD monitoring by TP53 duplex sequencing with APR-246 + azacitidine maintenance predicts outcomes.

David A Sallman, Amy F McLemore, Rami Komrokji

Pageof 5

Frequent Collaborators

21 joint publications

Taiga Nishihori

11 joint publications

Hany Elmariah

9 joint publications

Daniel Weisdorf

9 joint publications

Vijaya Raj Bhatt